Immunosafety is a dynamic and interdisciplinary field that  incorporates the evaluation of how new drugs, therapies, vaccines, food additives, cosmetics, and a variety of chemicals affect the immune system and to determine the relative “safety" of these entities in people, animals, and within the environment.

The primary objective of this training course is to promote  a greater understanding and use of immunosafety information in both the scientific community and society at large. The Cancer Immunotherapies module  designed to provide  the foundational biology while highlighting and describing therapeutic approaches across various modalities and discussing related safety issues. All lectures contained within this module are 45-60 minutes in duration.  While having some knowledge of basic cancer immunology is helpful, it is not required.  

Participants will have the flexibility to select topics based on interest and or need and can work towards obtaining a certificate of completion for completing course and quizzes contain in this module . 

This course is intended to serve as resource for those who are interested in learning about cancer immunotherapies  and/or looking for professional development opportunities in the form of continuing education and networking.